Benjamin Zorach
Advanced Heart Failure and Transplant Cardiology · Fall River, MANPI 1679969158
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (36.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Edwards Lifesciences at 42.7% of the total. 2025 is the largest year on record at $4,469, more than ten times the $442 reported in 2021.
Across 69 payments — averaging $110.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$3K
- Medtronic$2K
- Abbott$2K
- Boston Scientific$370
- Cardiovascular Systems Inc.$301
- Shockwave Medical, Inc$47
- plus $127 from 4 others
Across 1 payment — averaging $184.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$185
What the payments were for
- Consulting fees$2,58034%
- Travel & lodging$1,98226%
- Food & beverage$2,75336%
- Education$2804%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 14 | $3,241 |
| Medtronic | 20 | $1,931 |
| Abbott | 11 | $1,579 |
| Boston Scientific | 10 | $370 |
| Cardiovascular Systems Inc. | 5 | $301 |
| Shockwave Medical, Inc | 2 | $47 |
| Cardiva Medical, Inc. | 2 | $43 |
| Pfizer | 2 | $37 |
| Teleflex LLC | 2 | $28 |
| Terumo Medical Corporation | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SAPIEN 3 Ultra RESILIA$2,150
- TRICLIP$1,242
- COREVALVE EVOLUT R$1,012
- Edwards SAPIEN 3 Transcatheter Heart Valve$430
- Resolute$280
- Diamondback Coronary$222
- SYNERGY$121
How this compares
$7,595 in reported general payments places this provider in the 55th percentile of 35 advanced heart failure and transplant cardiology providers in Massachusetts.
See all advanced heart failure and transplant cardiology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 24 | $24,141 |
| BrilintaTicagrelor | 19 | $15,693 |
| EliquisApixaban | 15 | $14,330 |
| EntrestoSacubitril/Valsartan | 12 | $14,110 |
| Repatha SyringeEvolocumab | 11 | $6,359 |
| Metoprolol Succinate | 32 | $794 |
| Rosuvastatin Calcium | 27 | $484 |
| Atorvastatin Calcium | 32 | $464 |
| Amlodipine Besylate | 38 | $395 |
| ClopidogrelClopidogrel Bisulfate | 16 | $204 |
| Carvedilol | 14 | $71 |
| Furosemide | 13 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $37 | $14,33015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 35 advanced heart failure and transplant cardiology providers in Massachusetts.
Other advanced heart failure and transplant cardiology in Fall River
- Adam SaltzmanFall River$68K
- Pablo Quintero PinzonBoston$137K
- Sophia AirhartSpringfield$110K
- Daniel ZlotoffBoston$96K
- Christina Vander PluymBoston$55K
- Richard PattenBurlington$45K
- Monica AhluwaliaBoston$39K
- Stephanie MooreBoston$30K
- Mark TallmanBrighton$28K
- Sachin ShahBurlington$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.